Trial Profile
Treatment by Anti GP IIb/IIIa in the Setting of a Strategy of Early Coronarography to Patients With an Acute Coronary Syndrome Without ST Elevation.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Tirofiban (Primary)
- Indications Acute coronary syndromes; Cardiovascular disorders; Embolism and thrombosis
- Focus Therapeutic Use
- Acronyms SISCA
- 12 Mar 2010 New trial record